Pharmaceutical kits are provided that reduce or prevent oxidative degradation of oxygen-sensitive pharmaceutically active ingredients in solid unit dosage forms that are supplied in oxygen permeable containers. Stabilization of the active ingredient is accomplished by incorporating an oxygen absorber into a sealed oxygen permeable container.
所提供的药剂包可以减少或防止在透氧容器中供应的固体单位剂型中对氧敏感的药物活性成分的氧化降解。活性成分的稳定是通过在密封的透氧容器中加入
氧气吸收剂来实现的。